Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE:002332)
China flag China · Delayed Price · Currency is CNY
8.62
-0.10 (-1.15%)
May 20, 2026, 12:25 PM CST

SHE:002332 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
3,6413,7313,9804,0794,3584,335
Other Revenue
28.4328.4321.1743.9621.5222.46
3,6693,7594,0014,1234,3804,357
Revenue Growth (YoY)
-7.60%-6.04%-2.98%-5.85%0.52%8.42%
Cost of Revenue
1,4191,4971,7441,9721,8651,848
Gross Profit
2,2502,2622,2562,1522,5152,509
Selling, General & Admin
1,5381,4981,3441,2711,5321,560
Research & Development
301.98303.75265.17261266.77243.37
Other Operating Expenses
26.5926.1319.2622.0432.9232.73
Operating Expenses
1,8701,8331,6391,5471,8361,836
Operating Income
380.35428.98617.42604.79678.81672.92
Interest Expense
-5.22-4.64-3.13-3.37-6.29-23.1
Interest & Investment Income
15.416.7329.4838.2876.5443.19
Currency Exchange Gain (Loss)
-2.98-2.9810.57-9.3211.817.44
Other Non Operating Income (Expenses)
-8.12-3.53-2.7-5.53-11.25-5.26
EBT Excluding Unusual Items
379.43434.55651.63624.85749.6705.19
Gain (Loss) on Sale of Investments
-26.2-26.41-8.14-8.97-00.64
Gain (Loss) on Sale of Assets
45.8246.30.28-1.4891.6214.51
Asset Writedown
-1.76-1.76-1.31-0.42-0.91-1.68
Other Unusual Items
16.4510.64-170.8127.731.5811.2
Pretax Income
486.26535.84498.33641.68871.89729.87
Income Tax Expense
81.4683.2498.479.56124.49108.6
Earnings From Continuing Operations
404.81452.6399.92562.12747.4621.26
Minority Interest in Earnings
-5.27-2.96-2.740.972.01-1.94
Net Income
399.54449.64397.18563.08749.41619.33
Net Income to Common
399.54449.64397.18563.08749.41619.33
Net Income Growth
2.44%13.21%-29.46%-24.86%21.00%22.76%
Shares Outstanding (Basic)
999999993988989989
Shares Outstanding (Diluted)
999999993988989989
Shares Change (YoY)
0.64%0.63%0.51%-0.13%0.00%7.84%
EPS (Basic)
0.400.450.400.570.760.63
EPS (Diluted)
0.400.450.400.570.760.63
EPS Growth
1.78%12.50%-29.83%-24.76%21.00%13.84%
Free Cash Flow
181.2438.4191.07360.85326.74409.31
Free Cash Flow Per Share
0.180.040.190.360.330.41
Dividend Per Share
0.3000.3000.3000.3000.3000.150
Dividend Growth
----100.00%-
Gross Margin
61.32%60.18%56.40%52.18%57.42%57.58%
Operating Margin
10.37%11.41%15.43%14.67%15.50%15.44%
Profit Margin
10.89%11.96%9.93%13.66%17.11%14.21%
Free Cash Flow Margin
4.94%1.02%4.78%8.75%7.46%9.39%
EBITDA
593.08643.22837.73816.24866.26857.11
EBITDA Margin
16.16%17.11%20.94%19.79%19.78%19.67%
D&A For EBITDA
212.73214.24220.31211.45187.46184.19
EBIT
380.35428.98617.42604.79678.81672.92
EBIT Margin
10.37%11.41%15.43%14.67%15.50%15.44%
Effective Tax Rate
16.75%15.53%19.75%12.40%14.28%14.88%
Revenue as Reported
3,6693,7594,0014,1234,3804,357
Advertising Expenses
-860712.54685.06991.031,035
Source: S&P Global Market Intelligence. Standard template. Financial Sources.